Portal de Periódicos da CAPES

Reply to: Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens

2024; Wiley; Volume: 71; Issue: 5 Linguagem: Inglês

10.1002/pbc.30930

1545-5017

Laura Butragueño Laiseca, Sara de la Mata Navazo, Amelia Caridad Sánchez Galindo, María José Santiago,

Erythropoietin and Anemia Treatment

Pediatric Blood & CancerEarly View e30930 LETTER TO THE EDITOR Authors' reply: Intravenous iron for pediatric critically ill children Laura Butragueño-Laiseca, Corresponding Author Laura Butragueño-Laiseca [email protected] orcid.org/0000-0001-5430-0488 Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, Spain Correspondence Laura Butragueño Laiseca, Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, O´Donnell 48 28007, Madrid, Spain. Email: [email protected]Search for more papers by this authorSara de la Mata Navazo, Sara de la Mata Navazo Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this authorAmelia Caridad Sánchez Galindo, Amelia Caridad Sánchez Galindo Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this authorMaría José Santiago Lozano, María José Santiago Lozano Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this author Laura Butragueño-Laiseca, Corresponding Author Laura Butragueño-Laiseca [email protected] orcid.org/0000-0001-5430-0488 Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, Spain Correspondence Laura Butragueño Laiseca, Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, O´Donnell 48 28007, Madrid, Spain. Email: [email protected]Search for more papers by this authorSara de la Mata Navazo, Sara de la Mata Navazo Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this authorAmelia Caridad Sánchez Galindo, Amelia Caridad Sánchez Galindo Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this authorMaría José Santiago Lozano, María José Santiago Lozano Pediatric Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Gregorio Marañón Health Research Institute (IISGM), Madrid, Spain Pediatrics Department, Universidad Complutense de Madrid, Madrid, Spain Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Development Origin Network (RICORS) RD21/0012/0011, Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this author First published: 26 February 2024 https://doi.org/10.1002/pbc.30930Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Payán-Pernía S, Pérez-Simón JA, García-Erce JA. Comment on: intravenous iron for critically ill children. Comparison of three dose regimens. Pediatr Blood Cancer. 2024; 22:e30857. 10.1002/pbc.30857 Google Scholar 2Butragueño-Laiseca L, de la Mata Navazo S, Sánchez Galindo AC, Santiago Lozano MJ. Intravenous iron for critically ill children. Comparison of three dose regimens. Pediatr Blood Cancer. 2024; 71(1):e30734. 10.1002/pbc.30734 CASPubMedWeb of Science®Google Scholar 3Geneen LJ, Kimber C, Doree C, Stanworth S, Shah A. Efficacy and safety of intravenous iron therapy for treating anaemia in critically ill adults: a rapid systematic review with meta-analysis. Transfus Med Rev. 2022; 36(2): 97-106. 10.1016/j.tmrv.2021.12.002 PubMedWeb of Science®Google Scholar 4Chacón Aguilar R, Escorial Briso-Montiano M, Sopetrán Rey García M, García Sanz C, Rupérez Lucas M, López-Herce Cid J. Erythropoietin treatment in critically ill children. An Pediatr. 2004; 61: 398-402. Google Scholar 5Shokri H, Ali I. Intravenous iron supplementation treats anemia and reduces blood transfusion requirements in patients undergoing coronary artery bypass grafting: a prospective randomized trial. Ann Card Anaesth. 2022; 25: 141-147. 10.4103/aca.aca_209_20 PubMedWeb of Science®Google Scholar 6 IRONMAN Investigators, Litton E, Baker S, et al. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: a randomized trial of IV iron in critical illness. Intensive Care Med. 2016; 42: 1715-1722. 10.1007/s00134-016-4465-6 PubMedWeb of Science®Google Scholar 7Lasocki S, Asfar P, Jaber S, et al. Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial. Crit Care. 2021; 25: 62. 10.1186/s13054-020-03430-3 PubMedWeb of Science®Google Scholar 8Powers JM, Shamoun M, McCavit TL, Adix L, Buchanan GR. Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron. J Pediatr. 2017; 180: 212-216. 10.1016/j.jpeds.2016.09.053 CASPubMedWeb of Science®Google Scholar 9Crary SE, Hall K, Buchanan GR. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer. 2011; 56: 615-619. 10.1002/pbc.22930 PubMedWeb of Science®Google Scholar 10Mantadakis E, Tsouvala E, Xanthopoulou V, Chatzimichael A. Intravenous iron sucrose for children with iron deficiency anemia: a single institution study. World J Pediatr. 2016; 12: 109-113. 10.1007/s12519-015-0010-x CASPubMedWeb of Science®Google Scholar 11Ozsahin H, Schaeppi M, Bernimoulin M, Allard M, Guidard C, van den Ouweland F. Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: benefits and risks in a cohort of 144 children and adolescents. Pediatr Blood Cancer. 2020; 67:e28614. 10.1002/pbc.28614 CASPubMedWeb of Science®Google Scholar 12Sabe R, Vatsayan A, Mahran A, Khalili AS, Ahuja S, Sferra TJ. Safety and efficacy of intravenous iron sucrose for iron-deficiency anemia in children and adolescents with inflammatory bowel disease. Glob Pediatr Heal. 2019; 6:2333794X19870981. 10.1177/2333794X19870981 PubMedGoogle Scholar 13Kaneva K, Chow E, Rosenfield CG, Kelly MJ. Intravenous iron sucrose for children with iron deficiency anemia. J Pediatr Hematol Oncol. 2017; 39: e259-e262. 10.1097/MPH.0000000000000879 CASPubMedWeb of Science®Google Scholar 14Roganovic J. Parenteral iron therapy in children with iron deficiency anemia: a single-institution experience. Pediatr Blood Cancer. 2024; 18:e30866. 10.1002/pbc.30866 Google Scholar 15Cappellini MD, Comin-Colet J, de Francisco A, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017; 92(10): 1068-1078. 10.1002/ajh.24820 CASPubMedWeb of Science®Google Scholar 16Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018; 18: 2018. Google Scholar 17Cleland JGF. Defining iron deficiency in patients with heart failure. Nat Rev Cardiol. 2024; 21(1): 1-2. doi:10.1038/s41569-023-00951-6 10.1038/s41569-023-00951-6 PubMedWeb of Science®Google Scholar 18Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J. 2023; 44(1): 14-27. 10.1093/eurheartj/ehac569 PubMedWeb of Science®Google Scholar 19Abhyankar A, Moss AC. Iron replacement in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2015; 21(8): 1976-1981. 10.1097/MIB.0000000000000386 PubMedWeb of Science®Google Scholar 20Ganz T. Anemia of inflammation. N Engl J Med. 2019; 381(12): 1148-1157. 10.1056/NEJMra1804281 CASPubMedWeb of Science®Google Scholar 21 Agenda Española de medicamentos y productos sanitarios. Ficha técnica Venofer. CIMA; 2021. Accessed February 3, 2024. https://cima.aemps.es/cima/dochtml/ft/64000/FichaTecnica_64000.html Google Scholar 22 Agenda Española de medicamentos y productos sanitarios. Ficha técnica Ferinject. CIMA; 2024. Accessed February 3, 2024. https://cima.aemps.es/cima/dochtml/ft/69771/FT_69771.html Google Scholar Early ViewOnline Version of Record before inclusion in an issuee30930 ReferencesRelatedInformation